Abnormalities in electroencephalographic microstates are state and trait markers of major depressive disorder.


Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
11 2020
Historique:
received: 11 02 2020
accepted: 17 06 2020
revised: 15 06 2020
pubmed: 27 6 2020
medline: 24 6 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Neuroimaging studies have shown that major depressive disorder (MDD) is characterized by abnormal neural activity and connectivity. However, hemodynamic imaging techniques lack the temporal resolution needed to resolve the dynamics of brain mechanisms underlying MDD. Moreover, it is unclear whether putative abnormalities persist after remission. To address these gaps, we used microstate analysis to study resting-state brain activity in major depressive disorder (MDD). Electroencephalographic (EEG) "microstates" are canonical voltage topographies that reflect brief activations of components of resting-state brain networks. We used polarity-insensitive k-means clustering to segment resting-state high-density (128-channel) EEG data into microstates. Data from 79 healthy controls (HC), 63 individuals with MDD, and 30 individuals with remitted MDD (rMDD) were included. The groups produced similar sets of five microstates, including four widely-reported canonical microstates (A-D). The proportion of microstate D was decreased in MDD and rMDD compared to the HC group (Cohen's d = 0.63 and 0.72, respectively) and the duration and occurrence of microstate D was reduced in the MDD group compared to the HC group (Cohen's d = 0.43 and 0.58, respectively). Among the MDD group, proportion and duration of microstate D were negatively correlated with symptom severity (Spearman's rho = -0.34 and -0.46, respectively). Finally, microstate transition probabilities were nonrandom and the MDD group, relative to the HC and the rMDD groups, exhibited multiple distinct transition probabilities, primarily involving microstates A and C. Our findings highlight both state and trait abnormalities in resting-state brain activity in MDD.

Identifiants

pubmed: 32590838
doi: 10.1038/s41386-020-0749-1
pii: 10.1038/s41386-020-0749-1
pmc: PMC7547108
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2030-2037

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH095809
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101521
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH118565
Pays : United States

Références

Front Psychiatry. 2019 Aug 09;10:548
pubmed: 31474881
Front Neurol. 2019 Apr 04;10:325
pubmed: 31019487
Nat Commun. 2019 Feb 14;10(1):753
pubmed: 30765707
Neuroimage Clin. 2018;20:1176-1190
pubmed: 30388600
Neuroimage. 2012 Feb 15;59(4):3548-62
pubmed: 22116037
Neuroimage. 2010 Oct 1;52(4):1149-61
pubmed: 20139014
Neuroimage. 2017 Feb 1;146:533-543
pubmed: 27742598
Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):64-9
pubmed: 10026377
Neuroimage. 2002 May;16(1):41-8
pubmed: 11969316
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jan;5(1):35-44
pubmed: 31543456
Methods Find Exp Clin Pharmacol. 2002;24 Suppl D:5-12
pubmed: 12575463
Neuroimage. 2017 Nov 15;162:353-361
pubmed: 28847493
Neuroimage. 2011 Jan 1;54(1):313-27
pubmed: 20656036
Comput Intell Neurosci. 2011;2011:879716
pubmed: 21584256
Electroencephalogr Clin Neurophysiol. 1993 Oct;87(4):169-74
pubmed: 7691547
Neuroimage. 2012 May 1;60(4):2062-72
pubmed: 22381593
Front Psychiatry. 2016 Feb 26;7:22
pubmed: 26955358
Neurosci Biobehav Rev. 2015 Feb;49:105-13
pubmed: 25526823
Front Hum Neurosci. 2019 Feb 26;13:56
pubmed: 30863294
IEEE Trans Biomed Eng. 1995 Jul;42(7):658-65
pubmed: 7622149
Electroencephalogr Clin Neurophysiol. 1989 Feb;72(2):184-7
pubmed: 2464490
JAMA Psychiatry. 2015 Jun;72(6):603-11
pubmed: 25785575
Clin Neurophysiol. 2011 Jun;122(6):1073-4
pubmed: 21126907
Psychiatry Res. 2013 Sep 30;213(3):179-85
pubmed: 23850106
J Psychiatry Neurosci. 2013 Jan;38(1):49-56
pubmed: 22691300
Neuroreport. 2009 Mar 4;20(4):378-80
pubmed: 19218876
Neuroimage. 2019 Jul 1;194:82-92
pubmed: 30902640
Comput Intell Neurosci. 2011;2011:813870
pubmed: 21253358
Brain Connect. 2017 Dec;7(10):671-682
pubmed: 28938855
J Neural Transm Gen Sect. 1995;99(1-3):213-22
pubmed: 8579806
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jan;3(1):50-58
pubmed: 29397079
Neuroimage. 2010 Oct 1;52(4):1162-70
pubmed: 20188188
Neuroimage. 2018 Oct 15;180(Pt B):577-593
pubmed: 29196270
Neuroimage. 2012 Sep;62(3):2129-39
pubmed: 22658975
Neuroscientist. 2005 Aug;11(4):357-72
pubmed: 16061522
Brain Topogr. 2008 Jun;20(4):249-64
pubmed: 18347966
Depress Anxiety. 2014 Jun;31(6):506-16
pubmed: 24448889
Neuroimage. 2015 Jan 1;104:199-208
pubmed: 25451473

Auteurs

Michael Murphy (M)

Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
McLean Hospital, Belmont, MA, USA.

Alexis E Whitton (AE)

Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
McLean Hospital, Belmont, MA, USA.
University of Sydney, Sydney, Australia.

Stephanie Deccy (S)

McLean Hospital, Belmont, MA, USA.
Albert Einstein College of Medicine, Bronx, NY, USA.

Manon L Ironside (ML)

McLean Hospital, Belmont, MA, USA.
University of California-Berkeley, Berkeley, CA, USA.

Ashleigh Rutherford (A)

McLean Hospital, Belmont, MA, USA.
Yale University, New Haven, CT, USA.

Miranda Beltzer (M)

McLean Hospital, Belmont, MA, USA.
University of Virginia, Charlottesville, VA, USA.

Matthew Sacchet (M)

Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
McLean Hospital, Belmont, MA, USA.

Diego A Pizzagalli (DA)

Department of Psychiatry, Harvard Medical School, Boston, MA, USA. dap@mclean.harvard.edu.
Center for Depression, Anxiety, and Stress Research, McLean Hospital, Belmont, MA, USA. dap@mclean.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH